The Clorox Company (NYSE:CLX) Shares Sold by Korea Investment CORP

Korea Investment CORP cut its position in The Clorox Company (NYSE:CLX) by 8.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 19,672 shares of the company’s stock after selling 1,771 shares during the quarter. Korea Investment CORP’s holdings in Clorox were worth $3,195,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Public Employees Retirement System of Ohio increased its stake in Clorox by 26.3% during the third quarter. Public Employees Retirement System of Ohio now owns 59,766 shares of the company’s stock worth $9,736,000 after purchasing an additional 12,428 shares during the period. Fifth Third Wealth Advisors LLC purchased a new stake in Clorox during the 4th quarter worth approximately $204,000. Apollon Wealth Management LLC lifted its holdings in Clorox by 119.6% during the 4th quarter. Apollon Wealth Management LLC now owns 3,364 shares of the company’s stock worth $546,000 after buying an additional 1,832 shares in the last quarter. Miracle Mile Advisors LLC acquired a new position in shares of Clorox in the fourth quarter worth $1,566,000. Finally, Geode Capital Management LLC increased its position in shares of Clorox by 1.1% during the third quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock worth $491,713,000 after acquiring an additional 33,970 shares during the period. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Up 0.4 %

Shares of NYSE CLX opened at $147.79 on Wednesday. The stock has a market cap of $18.21 billion, a PE ratio of 40.38, a price-to-earnings-growth ratio of 2.62 and a beta of 0.45. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37. The business has a 50-day moving average price of $150.83 and a 200 day moving average price of $158.74. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52.

Clorox (NYSE:CLX) last announced its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter last year, the firm earned $2.16 EPS. Equities research analysts forecast that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.30%. The ex-dividend date is Wednesday, April 23rd. Clorox’s dividend payout ratio is currently 133.33%.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the company. JPMorgan Chase & Co. boosted their target price on Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. DA Davidson cut their target price on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 5th. Evercore ISI lifted their price target on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. StockNews.com downgraded shares of Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and set a $150.00 price objective on shares of Clorox in a research report on Thursday, January 30th. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $159.50.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.